Novo Nordisk is buying a vaccine manufacturing factory from Novavax for $200 million to expand production of its current and ...

AstraZeneca appointed Iskra Reic as EVP of international to lead China operations after Leon Wang's suspension. Multiple companies shared updates: Janux announced $300M offering, Eli Lilly partnered ...

Relmada Therapeutics said Wednesday morning that a Phase 3 study testing its major depression drug, REL-1017, is likely to ...

GeneDx was teetering. The genetic testing company had laid off 33% of its staff, shares were down 90% from a year prior, and ...

UnitedHealthcare CEO Brian Thompson was shot and killed in Midtown Manhattan on Wednesday morning, according to media reports ...

Atea Pharmaceuticals reported positive Phase 2 trial results for its hepatitis C combination therapy of bemnifosbuvir and ...

The market for first-generation weight loss treatments has been dominated by two major players, Eli Lilly and Novo Nordisk.

GSK partners with Duality Biologics in a $30 million upfront deal, potentially worth $975 million, for access to a ...

Versant is out with its third obesity biotech of the year, leading an €80 million Series A for Antag Therapeutics, a Danish ...

Eli Lilly has removed the commonly used clinical measure of body mass index from the FDA label for its weight loss drug ...

GSK has axed a Phase 2 study of a chronic hepatitis B therapeutic vaccine, adding to a string of treatment R&D hurdles for the liver infection.

The SEC said Tuesday that it settled charges filed against Kiromic Biopharma, a tiny immuno-oncology startup based in Texas, ...